Article
Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy.
International journal of hematology - 1 Dec 2013
Yanagimachi Masakatsu, Goto Hiroaki, Kaneko Tetsuji, Naruto Takuya, Sasaki Koji, Takeuchi Masanobu, Tanoshima Reo, Kato Hiromi, Yokosuka Tomoko, Kajiwara Ryosuke, Fujii Hisaki, Tanaka Fumiko, Goto Shoko, Takahashi Hiroyuki, Mori Masaaki, Kai Sumio, Yokota Shumpei
Abstract excerpt
High-dose methotrexate therapy (HD-MTX) has been well established for the treatment of childhood acute lymphoblastic leukemia (ALL). The aims of this study were to investigate whether clinical and pharmacogenetic factors influence plasma MTX concentration and renal dysfunction in patients treated with HD-MTX. In a total of 127 courses of HD-MTX in 51 patients with childhood ALL, influence of clinical and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
